• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PRA to acquire CRI Lifetree, boosting global phase I presence

PRA to acquire CRI Lifetree, boosting global phase I presence

November 13, 2013
CenterWatch Staff

PRA, a CRO based in Raleigh, N.C., intends to acquire privately held CRI Lifetree, a research organization that focuses on early stage, patient population studies.

Therapeutically, CRI Lifetree is focused in human abuse liability (HAL), addiction, pain, psychiatry, neurology, pediatric and infectious disease services. With more than 20 years in clinical research, the company has three clinical pharmacology centers with a capacity of about 200 beds, making it one of the largest providers of patient population phase I and confined phase II-III services in the U.S.

According to the company, CRI Lifetree is among only a few centers in the world with the ability to design and conduct HAL studies, a regulatory-required study for central nervous system (CNS) compounds. 

The acquisition, said PRA, will enable it to grow its phase I-II services and provide clients a full range of services in specialized patient populations for both inpatient and outpatient settings. CRI Lifetree adds to PRA’s existing phase I and bioanalytical lab capabilities in the U.S. and Europe.

“CRI Lifetree highly complements PRA’s services and capabilities,” said Colin Shannon, PRA’s president and CEO. “Together we are building a leading early phase CNS platform capable of providing clients with a comprehensive set of specialized clinical services.”

“PRA’s Early Development Services (EDS) division and CRI Lifetree are a perfect fit,” said Willem Jan Drijfhout, executive vice president, EDS and managing director. “We both have a strong scientific foundation and now, with a total of 500 beds and eight clinical pharmacology units, we will be one of the largest phase I organizations in the world.”

“There is a very strong cultural fit between CRI Lifetree and PRA,” said Jeffrey Kinell, CEO of CRI Lifetree. “Both companies share a dedication to scientific leadership, expansion of highly specialized services to meet the emerging needs of our clients, an uncompromising focus on quality and a belief that our strength is in our people and the way in which they work together.”

CRI Lifetree has approximately 250 full-time employees, is headquartered in Mount Laurel, N.J., and has three clinic locations: Marlton, N.J., Philadelphia and Salt Lake City. In addition to inpatient and outpatient studies, the company provides specialized early-phase research support services such as data management, biostatistics and study report writing.

PRA’s 10,000+ employees operate in more than 80 countries, providing full-service and embedded clinical trial solutions.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing